Atlas Trials

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

Clinical trial NCT04856371 · UNKNOWN

Trial details

NCT number
NCT04856371
Sponsor
Haihe Biopharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Breast Cancer
Start date
2021-04-01
Primary completion
2022-03-01
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.